Learning objectives

After watching this webinar, participants will:

• appreciate the complexities of risk-stratified and stage-adapted approaches to antithrombotic management in secondary prevention of ACS, especially for patients with HBR;
• be able to weigh recurrent bleeding and thrombotic risk by individual assessment;
• comprehend available RC trials and RWE studies with P2Y12 inhibitors; and
• understand maintenance strategies, including de-escalation, to mitigate adverse effects for ACS patients with HBR.

Needs assessment and expected educational outcome

To understand the complexities of when and for which ACS patients DAPT de-escalation strategy may improve clinical outcomes and to understand the multiple risk-stratifying methods that should guide such decisions. 

Main topic

• Acute coronary syndrome

Related topics

• Acute Coronary Syndromes - Treatment - Pharmacotherapy - Antiplatelet Agents
• High bleeding risk (HBR)
• Coronary artery disease

Session information

This webinar is designed for Cardiologists in training as well as senior doctors taking care for CAD patients with ACS across the spectrum of low to high bleeding risk patients.

During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide live feedback.

Technical settings

The webinar is available on PC and tablets. The use of a smartphone is not recommended.

To answer the MCQs during the live, you must allow pop-up windows.

A high-speed Internet connection is required (minimum 2 Mbps).